Sonicincytes
AI-guided point-of-care ultrasound device that measures liver stiffness for clinicians assessing MASLD and MASH
Highlights
- New on EvolcAdded 2026-11-11
About Sonicincytes
Sonic Incytes Medical Corp. develops Velacur ONE, an AI-guided ultrasound elastography system for assessing chronic liver disease at the point of care. The device measures liver stiffness and attenuation, which the company describes as comparable to MRE/MRI-PDFF and biopsy for MASLD and MASH.
The system is aimed at healthcare providers, and the procedure can be performed in-office by a trained medical professional. The company also works with academic leaders and life-science partners. The company cites a low up-front cost and higher reimbursement than other non-imaging elastography methods.
The company was founded in 2017 in Vancouver, British Columbia. The U.S. FDA granted 510(k) clearance for Velacur ONE, as announced in August 2025, and the company was named 2026 MedTech Emerging Company of the Year. Its current job listing is for a Marketing Coordinator in Vancouver.
Product: Velacur ONE, a portable AI-guided ultrasound elastography device for non-invasive assessment of liver stiffness and attenuation in chronic liver disease.
Jobs at Sonicincytes
More health & medtech companies
Sonus Microsystems
Wearable cardiac ultrasound and customizable transducers for healthcare providers and patientsNew on EvolcSpectrum Health Care
Home health care, senior companionship and nursing for patients and families in Ontario and QuebecNew on EvolcSyreon
Clinical research and health economics services for biotech, pharmaceutical, diagnostic and medical-device companiesNew on EvolcVitalBio
Point-of-care blood testing systems for healthcare providers and clinical practicesNew on EvolcAkinox
Digital healthcare platforms and services for public and private healthcare organizationsNew on EvolcAlayaCare
Cloud software platform for home-based care providers managing clinical, operational, billing, and care-delivery workflows
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.